Remove 2009 Remove Biopharma Remove Leads
article thumbnail

EU pharmaceutical legislation revisions: what are the implications for biopharma?

European Pharmaceutical Review

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. However, it is clear that changes are likely to have meaningful impacts for biopharma players if adopted.

article thumbnail

Divest to invest: the new normal in biopharma?

European Pharmaceutical Review

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. The post Divest to invest: the new normal in biopharma?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Artificial Intelligence for better antibody drugs: ready for prime time?

pharmaphorum

As a result, 2022 saw a breakthrough when the first ever computationally designed antibody created by Israel-based Biolojic design entered clinical trial , further fuelling the interest of biopharma companies. Consequently, the lead optimisation or molecular evolution offerings in the space are relatively more common among the start-ups.

Biopharma 107
article thumbnail

Restructuring announced at ReNeuron as another CEO resigns

pharmaphorum

Catherine Isted has stepped down as chief executive of UK biotech ReNeuron with immediate effect, with board member and biopharma industry veteran Iain Ross appointed as executive chairman with a remit to revamp the business. Isted joined ReNeuron as chief financial officer in 2021, before stepping up to the top job for just a few months.

article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

A just-published report from the Medicines Manufacturing Industry Partnership (MMIP) – set up by the UK government and biopharma industry in 2014 to drive growth in the category – says the sector has the potential to be a driver for the UK economy in the next decade. Established trends are unfortunately firmly in the wrong direction.

article thumbnail

The PM360 Trailblazer Awards 2023 Winners

PM360

Established in 2009, the Trailblazer Awards recognize and honor outstanding companies, marketers, marketing teams, brand managers, and initiatives that have demonstrated innovation and achieved incredible results in the life sciences. Diversity/Multicultural: Anna Czene, Vice President, Corporate Communications & DEI Lead, CareDx, Inc.

Education 122
article thumbnail

The role of artificial intelligence or machine learning in conducting systematic literature reviews now and in future

Clarivate

They differ from traditional literature reviews in that they typically adhere to strict methodological guidelines such as those issued by the Cochrane Collaboration (Cochrane, 2019) and the Centre for Reviews & Dissemination (Centre for Reviews and Discussion, 2009). Centre for Reviews and Discussion, 2009. Cochrane Crowd [Online].